United States Contraceptive Devices Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The United States contraceptive devices market was valued at USD 2.27 Billion in 2025. It is poised to grow at a CAGR of 6.30% during the forecast period of 2026-2035, and reach USD 4.18 Billion by 2035. The market growth is driven by the rising use of long-acting reversible contraceptives and strong insurance coverage for family planning.

Latest News on the United States Contraceptive Devices Market (2026)

April 2026: Rising Condom Prices Highlight Global Supply Pressures

Global supply disruptions are influencing contraceptive pricing trends, with potential spillover effects on the United States market. According to Reuters, concerns over rising condom prices linked to geopolitical tensions are driving consumer reactions and stockpiling behavior, indicating pricing volatility that may impact procurement and distribution strategies across major markets including the U.S.

March 2026: US Litigation Over IUD Devices Advances In Federal Court

Legal developments involving contraceptive devices are shaping the regulatory landscape in the United States. As reported by Reuters, a federal judge allowed litigation over Paragard intrauterine devices to proceed, involving thousands of lawsuits, which may influence product safety scrutiny, regulatory oversight, and manufacturer compliance requirements in the contraceptive devices market.

January 2026: Organon Gains FDA Approval to Extend NEXPLANON Use to Five Years

According to the US FDA approval, Organon received clearance for a supplemental New Drug Application extending the approved duration of NEXPLANON use to five years. The approval strengthens the long-acting reversible contraceptive segment and supports wider adoption by offering women an extended efficacy window with a single implant.

Key Market Trends and Insights

• By product type, female contraceptive devices are expected to lead the market in the forecast period.
• By technology, non-hormonal (barrier) contraceptives are likely to hold a significant share of of the market in the forecast period.
• By distribution channel, retail pharmacy is anticipated to have a major market share in the forecast period.

Market Size and Forecast

• Market Size (2025) : USD 2.27 Billion
• Projected Market Size (2035) : USD 4.18 Billion
• CAGR (2026-2035) : 6.30%

United States Contraceptive Devices Market Overview

Contraceptive devices are medical products designed to prevent pregnancy by creating physical or hormonal barriers during sexual activity. These include condoms, intrauterine devices, subdermal implants, vaginal rings, sponges, and diaphragms. The United States market is driven by strong insurance coverage under the Affordable Care Act, a high unintended pregnancy rate, and a growing preference for long-acting reversible contraceptives. The market was valued at USD 2.27 Billion in 2025 and is expected to grow at a CAGR of 6.30% through 2035, reflecting strong adoption across healthcare providers, pharmacies, and e-commerce platforms. Innovations and government initiatives continue to support market expansion and accessibility.

United States Contraceptive Devices Market Growth Drivers

Rising Adoption of Long-Acting Reversible Contraceptives to Accelerate Market Demand

The growing shift toward long-acting reversible contraceptives (LARCs) is a key catalyst for the United States contraceptive devices market. According to the Centers for Disease Control and Prevention, 10.5% of women aged 15 to 49 were currently using an intrauterine device or subdermal implant between 2022 and 2023. This high prevalence indicates a growing awareness and acceptance of family planning measures, alongside supportive healthcare policies and educational initiatives. Such developments are expected to propel the demand for advanced and diverse contraceptive devices, contributing significantly to sustained growth in the coming years.

United States Contraceptive Devices Market Trends

Some of the notable trends in the market include the rising expansion of non-hormonal contraceptive innovation, new FDA approvals, and growing consumer preference for hormone-free options.

Expansion of Non-Hormonal Contraceptive Innovation is Likely to Boost the Market Value

The United States contraceptive devices market growth is increasingly driven by hormone-free innovations that address consumer concerns over systemic hormonal exposure. In February 2025, Sebela Women's Health received FDA approval for MIUDELLA, the first new hormone-free copper IUD approved in the United States in more than 40 years. This trend is further supported by ongoing research into next-generation materials, positioning non-hormonal devices as a key growth avenue in the evolving contraceptive landscape.

United States Contraceptive Devices Market Segmentation

Market Breakup by Product Type

• Male Contraceptive Device
• Condoms
• Spermicides
• Female Contraceptive Device
• Female Condoms
• Contraceptive Sponges
• Contraceptive Vaginal Rings
• Intrauterine Devices
• Sub-dermal Contraceptive Implants
• Non-Surgical Permanent Contraceptive Devices

Market Breakup by Technology

• Hormonal Contraceptives
• Barrier Contraceptives

Market Breakup by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Channel
• Public Channel
• Others

United States Contraceptive Devices Market Share

Intrauterine Devices are Expected to Lead the Market Segmentation by Product Type

Intrauterine devices are expected to lead the female contraceptive device segment in the United States, supported by high clinical effectiveness and strong physician preference. The category benefits from extended-duration approvals such as Mirena (up to 8 years) and Nexplanon (up to 5 years). According to the Centers for Disease Control and Prevention, LARC use among women aged 15 to 49 reached 16.2% in 2023. Expanding insurance coverage and streamlined placement tools further reinforce the dominance of IUDs.

Leading Players in the United States Contraceptive Devices Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Bayer AG

Bayer AG is a healthcare and pharmaceutical company actively involved in the market. The company offers a wide range of hormonal contraceptives, including oral pills, intrauterine systems, patches, vaginal rings, implants, and injectables. It also invests significantly in research and development to enhance safety, efficacy, and user comfort across its contraceptive portfolio.

Cooper Surgicals

Cooper Surgicals is a U.S.-based medical device company specializing in women’s health and reproductive care solutions. Its key product, Paragard®, is a non-hormonal copper intrauterine contraceptive device widely prescribed in the United States contraceptive devices market. The company actively supports patient education and awareness initiatives, strengthening its position in the market through improved accessibility and informed contraceptive choices.

Organon & Co.

Organon & Co. is a global healthcare company focused on advancing women’s health through a broad portfolio of medicines and contraceptive products. In recent news, the company acquired full ownership rights to Marvelon® and Mercilon®, combined oral hormonal contraceptive pills, across key Asian markets, strengthening its global contraception portfolio. Through strategic acquisitions and continued investment, Organon remains actively involved in the contraceptive device market worldwide.

Pfizer Inc.

Pfizer is a major player in women's health, with Depo-Provera injectable contraceptive as a key product. The company continues to expand its specialty injectable portfolio through commercial execution. Pfizer's scale across hospital and retail pharmacy networks supports broad contraceptive access.

Other key players in the market are Abbvie Inc., Church & Dwight Co., Inc., HLL Lifecare Ltd., and Reckitt Benckiser Group PLC.

Key Questions Answered in the United States Contraceptive Devices Market Report

• What was the United States contraceptive devices market value in 2025?
• What is the United States contraceptive devices market forecast outlook for 2026-2035?
• What major factors aid the demand for the United States contraceptive devices market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major United States contraceptive devices market trends?
• Which product type is expected to dominate the market segment?
• Which technology is projected to lead the market segment?
• Which distribution channel is likely to dominate the market segment?
• Who are the key players in the United States contraceptive devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?